Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients

英语/西班牙语双移动增强现实疼痛评估应用程序减少西班牙裔/拉丁裔儿童和青少年癌症患者术后处方阿片类药物使用的可行性

基本信息

  • 批准号:
    10601606
  • 负责人:
  • 金额:
    $ 25.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2023-09-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Hispanic/Latino youth are at the highest risk for prescription opioid misuse for pain indications amongst all minority populations in the United States. There are few legitimate clinical indications for prescribing opioids to children and adolescents, as early opioid use is a known “gateway” to adulthood dependence and substance abuse disorders. Cancer and major surgery are two critical medical conditions that when put together, cause children and adolescents to experience significant pain from the time of diagnosis into adulthood as survivors and put them at higher risk for persistent and chronic prescription opioid use and dependency. In perioperative settings, clinical decisions on opioid prescribing are dependent on rapid, verbal communication of pain intensity levels and adverse events between the clinical staff, the pediatric patient, and most often, family members in the acute care setting. Spanish-speaking Hispanic/Latino patients and/or adult caregivers with limited English proficiency are forced to rely on the availability of institutional translation services or the presence of bilingual clinical staff, which may not be readily available or easy to use. These infrastructural barriers, exacerbated in low or middle-income hospitals, put these patients at higher risk of inaccurate pain assessments, both under and over-treatment of their pain, and exposure to inappropriate amounts of prescription opioids. Our goal is to reduce inaccurate assessment and treatment of pain and opioid prescribing in Hispanic/Latino children and adolescents with cancer undergoing major surgery with a rapid, dual English/Spanish-language, age-appropriate, engaging mobile augmented reality (AR) tool that can help them and their families to communicate information about their acute pain and pain-related adverse events in the immediate postoperative inpatient setting. To achieve this goal, we have collaborated with bilingual native Spanish- speaking pediatric anesthesiologists and pain specialists at the MD Anderson Cancer Center to develop the app with content relevant and engaging to Hispanic and non-Hispanic pediatric populations and will demonstrate the feasibility of implementing the app in the postoperative anesthesia care unit in a Phase I clinical trial. To our knowledge, there are no studies to investigate mobile AR for enhancing pain management focused on this population. As most children with cancer are expected to survive long-term, the benefits of preventing inappropriate prescription opioid use in this high-risk pain population will last over the lifetime of a child.
项目摘要/摘要 西班牙裔/拉丁裔青年滥用处方阿片类药物治疗疼痛症状的风险最高 美国的少数民族人口。几乎没有合法的临床适应症来开阿片类药物到 儿童和青少年,因为早期使用阿片类药物是成年期依赖和物质的已知“门户” 虐待障碍。癌症和大手术是两种关键的医疗条件,当放在一起时,会导致 儿童和青少年从被诊断为幸存者到成年后经历巨大的痛苦 并使他们面临持续和慢性处方阿片类药物使用和依赖的更高风险。围手术期 环境,阿片类药物处方的临床决定依赖于疼痛强度的快速、口头沟通 临床工作人员、儿科患者和家庭成员之间的水平和不良事件 急诊护理环境。说西班牙语的西班牙裔/拉丁裔患者和/或英语水平有限的成年照顾者 熟练程度被迫依赖于机构翻译服务的可用性或双语的存在 临床工作人员,他们可能不容易找到或不容易使用。这些基础设施障碍在 低收入或中等收入医院,使这些患者面临更高的疼痛评估不准确的风险,两者都在 以及过度治疗他们的疼痛,以及接触不适当数量的处方阿片类药物。 我们的目标是减少西班牙裔/拉丁裔对疼痛和阿片类药物处方的不准确评估和治疗 接受大手术的癌症儿童和青少年使用快速、双语的英语/西班牙语, 适合年龄的、具有吸引力的移动增强现实(AR)工具,可帮助他们及其家人 即时交流有关他们的急性疼痛和疼痛相关不良事件的信息 术后住院环境。为了实现这一目标,我们与母语为双语的西班牙语合作- 与MD Anderson癌症中心的儿科麻醉师和疼痛专家交谈,以开发 APP具有与西班牙裔和非西班牙裔儿科人口相关和吸引人的内容,并将 论证在第一阶段的术后麻醉护理病房实施APP的可行性 临床试验。据我们所知,目前还没有关于移动AR增强疼痛管理的研究 把重点放在这群人身上。由于大多数癌症儿童预计都能长期存活,因此 在这一高风险疼痛人群中预防不适当的处方阿片类药物使用将持续一生 孩子。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Juan Pablo Cata其他文献

Juan Pablo Cata的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Juan Pablo Cata', 18)}}的其他基金

Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients
英语/西班牙语双移动增强现实疼痛评估应用程序减少西班牙裔/拉丁裔儿童和青少年癌症患者术后处方阿片类药物使用的可行性
  • 批准号:
    10741922
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer
增强现实平台可减少儿科癌症术后和长期阿片类药物的使用
  • 批准号:
    10471451
  • 财政年份:
    2020
  • 资助金额:
    $ 25.6万
  • 项目类别:
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer
增强现实平台可减少儿科癌症术后和长期阿片类药物的使用
  • 批准号:
    10416115
  • 财政年份:
    2020
  • 资助金额:
    $ 25.6万
  • 项目类别:
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer
增强现实平台可减少儿科癌症术后和长期阿片类药物的使用
  • 批准号:
    10013076
  • 财政年份:
    2020
  • 资助金额:
    $ 25.6万
  • 项目类别:

相似海外基金

Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
  • 批准号:
    10778757
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
  • 批准号:
    10783106
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
  • 批准号:
    10740796
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
  • 批准号:
    10599401
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
  • 批准号:
    575854-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
  • 批准号:
    467076
  • 财政年份:
    2021
  • 资助金额:
    $ 25.6万
  • 项目类别:
    Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
  • 批准号:
    9979265
  • 财政年份:
    2020
  • 资助金额:
    $ 25.6万
  • 项目类别:
Endocannabinoid Metabolism in Acute Pain
急性疼痛中的内源性大麻素代谢
  • 批准号:
    10356880
  • 财政年份:
    2020
  • 资助金额:
    $ 25.6万
  • 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
  • 批准号:
    10218273
  • 财政年份:
    2020
  • 资助金额:
    $ 25.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了